Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-08-27

FDA Approved: ZENPEP — Original Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

FDA approves Zenpep (pancrelipase) in an Original Application for the treatment of exocrine pancreatic insufficiency due to conditions such as cystic fibrosis a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZENPEP (pancrelipase)

Snippet

ORIG AP for ZENPEP (PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE)